Submitted by Anonymous (not verified) on 21 September 2023 - 10:59
Orphan designation: Talquetamab, Treatment of multiple myeloma, 20/08/2021, Positive
Source:
Orphan designation: Talquetamab, Treatment of multiple myeloma, 20/08/2021, Positive